Related Experiment Videos
Neutropenic enterocolitis.
1Department of Gastrointestinal Medicine and Nutrition, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 436, Houston, TX 77030-4009, USA. mdavila@mdanderson.org.
Current Treatment Options in Gastroenterology
|August 12, 2006
Summary
Neutropenic enterocolitis, a severe GI complication of chemotherapy, requires prompt recognition. Management is individualized, typically starting conservatively with bowel rest and antibiotics, escalating to surgery for complications like perforation.
Area of Science:
- Gastroenterology
- Hematology
- Oncology
Background:
- Neutropenic enterocolitis (NE) is a critical gastrointestinal complication following chemotherapy, frequently seen in leukemia and lymphoma patients.
- Early diagnosis and intervention are crucial for patient survival due to the high mortality rate associated with NE.
Purpose of the Study:
- To review current understanding and management strategies for neutropenic enterocolitis.
- To highlight the controversies and lack of high-quality evidence in NE treatment.
Main Methods:
- Review of existing literature, including case studies and retrospective reports, due to the absence of prospective or high-quality retrospective research.
- Analysis of common treatment approaches and indications for surgical intervention.
Main Results:
- Management of NE is controversial, with no uniform strategy due to limited robust studies.
- An individualized, case-specific approach is recommended, balancing conservative and surgical interventions.
- Conservative management includes bowel rest, IV fluids, TPN, antibiotics, and neutrophil count normalization.
Conclusions:
- Neutropenic enterocolitis necessitates an individualized treatment strategy.
- Early conservative management is generally agreed upon, with surgery reserved for specific severe complications.
- Further high-quality research is needed to establish definitive evidence-based guidelines for NE management.